Key result
Cicletanine improved myocardial function and reduced the incidence of irreversible ventricular fibrillation during reperfusion in isolated rat hearts, whereas nitrendipine had no effect on arrhythmias.
Why the study?
Does cicletanine improve cardiac function and reduce reperfusion-induced ventricular arrhythmias in isolated rat hearts subjected to ischemia/reperfusion compared to nitrendipine?
Does cicletanine improve cardiac function and reduce reperfusion-induced ventricular arrhythmias in isolated rat hearts subjected to ischemia/reperfusion compared to nitrendipine?
In an isolated rat heart model, cicletanine improved myocardial function and reduced irreversible ventricular fibrillation during ischemia/reperfusion compared to nitrendipine.
Answers are grounded in this paper and cite their sources.
Cicletanine preserved post-ischemic function and reduced arrhythmias in rat hearts; leaves open translation to clinical cardioprotection.
The effect of cicletanine, a novel furopyridine antihypertensive drug was compared with that of nitrendipine, a dihydropyridine slow calcium channel blocker, on cardiac function and reperfusion-induced ventricular arrhythmias in isolated working rat hearts subjected to 10-min ischemia induced by ligation of the left main coronary artery followed by 10-min reperfusion. Before ischemia, cicletanine and nitrendipine, perfused at concentrations of 3 x 10(-5), 6 x 10(-5), 10(-4), and 2 x 10(-4) or 10(-8) M, respectively, did not influence heart rate (HR), LV developed pressure (LVDP), its first derivative (LVdP/dtmax), and LV end-diastolic pressure (LVEDP), whereas aortic flow (AF) was decreased by 2 x 10(-4) M cicletanine only. Coronary flow (CF) remained unchanged by various cicletanine concentrations but was slightly increased by nitrendipine. In the concentration range of 3 x 10(-5)-10(-4) M, cicletanine improved AF either in ischemia or during reperfusion, whereas 2 x 10(-4) M had no such effect. Nitrendipine slightly attenuated ischemia/reperfusion-induced decrease in AF. Cicletanine and nitrendipine enhanced LVDP during ischemia. Ischemia-induced deterioration of LVdP/dtmax was reduced by cicletanine, during reperfusion, but this parameter was reduced by nitrendipine and the highest cicletanine concentration. Cicletanine decreased LVEDP significantly during ischemia and reperfusion, but nitrendipine had no such effect. All cicletanine concentrations reduced the incidence of irreversible ventricular fibrillation (VF) during reperfusion, an effect roughly concentration dependent in the range of 3 x 10(-5)-10(-4) M, whereas nitrendipine had no influence on arrhythmias.
No takes yet. Share an insight, caveat, or question.
Ferdinandy et al. (1992) studied Ischemia/reperfusion-induced myocardial dysfunction and ventricular arrhythmias. Cicletanine vs. Nitrendipine (10(-8) M) was evaluated on Cardiac function and reperfusion-induced ventricular arrhythmias. Cicletanine improved myocardial function and reduced the incidence of irreversible ventricular fibrillation during reperfusion in isolated rat hearts, whereas nitrendipine had no effect on arrhythmias.
Synapse has enriched 10 related papers. Consider them for comparative context: